Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Precision Psychiatry Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global precision psychiatry market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global precision ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
-
Alzheimer’s Disease Drugs
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Donepezil, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$5.2 Billion by the ... Read More
-
Alzheimer's Drugs – A Global Market Overview
... 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Alzheimer's Drugs Market Report by Drug Class (Cholinesterase Inhibitors NMDA Receptor Antagonist Combination Drugs and Others), Drug Type (Galantamine, Donepezil, Memantine, Rivastigmine, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Company Analysis 2024-2032
... Company Analysis 2024-2032 The global Alzheimer's drug market reached US$ 6.95 Billion in 2023 and is expected to reach US$ 15.08 Billion through 2032, with a CAGR of 8.99 percent from 2024 to 2032. Alzheimer's ... Read More
-
Wearable EEG Headsets Market Size, Share & Trends Analysis Report By Application (Trauma & Surgery, Disease Diagnosis), By Product, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Trends The global wearable EEG headsets market size is expected to reach USD 244.9 million by 2030, growing at a CAGR of 10.47% from 2024 to 2030, according to a new report by Grand View ... Read More
-
Milk Beverage Market Size Outlook, 2024- by Type (Kefir, Butter Milk, Ayran, Others), Categories (Flavored Drink, Unflavored Drink), Distribution channel (Supermarkets, Convenience stores, Online Channels, Others), End User (Adult, Children, Hotels, Others)- Industry Growth, Trends, Opportunities, Share, and Companies Analysis to 2032 Report
... Opportunities, Share, and Companies Analysis to 2032 Report The Milk Beverage market is poised to register a CAGR of 6.15% between 2024 and 2032. The market growth is driven by steady demand and new product ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
-
Argentina Alzheimer's Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the Alzheimer’s drugs market are highlighted in the study. ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Precision Psychiatry Market Report by Product Type (Products, Services), Sample (Blood-Based, Non-Blood-Based), Biomarker Type (Genetic Biomarker, Protein Biomarker), Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray, Immunoassay, Liquid Chromatography-Mass Spectrometry (LC-MS), and Others), Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2024-2032
... Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2024-2032 The global precision psychiatry market size reached US$ 1,059.7 Million in 2023. ... Read More
-
2024 Global Forecast for Alzheimer'S Disease Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029
... projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues due to the growing geriatric population ... Read More
-
Oral Clinical Nutrition Market Size, Trends, Analysis, and Outlook By Stage (Adults, Pediatrics), By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), by Region, Country, Segment, and Companies, 2024-2030
... (Online Sales, Retail Sales, Institutional Sales), by Region, Country, Segment, and Companies, 2024-2030 The global Oral Clinical Nutrition market size is poised to register 6.09% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
Research Assistance
